Lexicon Pharmaceuticals, Inc.
(NASDAQ : LXRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.73%104.101.1%$1332.57m
GILDGilead Sciences, Inc.
0.04%72.440.9%$675.30m
AMGNAmgen Inc.
-0.45%170.001.1%$499.55m
BIIBBiogen Inc.
0.00%313.971.2%$468.09m
REGNRegeneron Pharmaceuticals, Inc.
-0.79%391.592.7%$363.74m
ALXNAlexion Pharmaceuticals, Inc.
0.49%110.871.9%$288.55m
VRTXVertex Pharmaceuticals Incorporated
-0.36%147.411.9%$237.28m
INCYIncyte Corporation
-0.95%105.472.5%$187.59m
ALNYAlnylam Pharmaceuticals, Inc
0.89%127.5110.6%$184.43m
ILMNIllumina, Inc.
0.25%209.023.5%$165.18m
NKTRNektar Therapeutics
0.13%44.996.1%$146.11m
JUNOJuno Therapeutics, Inc.
1.56%58.6413.5%$138.44m
BMRNBioMarin Pharmaceutical Inc.
0.39%82.884.4%$117.68m
SRPTSarepta Therapeutics, Inc.
1.94%56.1116.8%$117.17m
BLUEBluebird Bio, Inc.
1.90%163.2017.2%$116.94m

Company Profile

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.